FMED
Exchange-traded product on NASDAQ (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Aug 31, 2026
The full portfolio as of the quarter end Aug 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Oct 26, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of May 31, 2026.
74 lines, 68 linked, weights sum to 104.45% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC | US88025U1097 | Equity | 42,800 | −2,200 | 5.19% | $ 2.673M |
|
Fidelity Revere Street Trust
|
US31635A3032 | Money market | 2,284,300.649 | −1,921,797.821 | 4.43% | $ 2.285M |
| THERMO FISHER SCIENTIFIC INC | US8835561023 | Equity | 3,200 | +1,924 | 3.83% | $ 1.975M |
| DANAHER CORP | US2358511028 | Equity | 9,000 | +1,325 | 3.73% | $ 1.922M |
| NATERA INC | US6323071042 | Equity | 5,280 | +2,665 | 3.30% | $ 1.7M |
| ARGENX SE | US04016X1019 | Equity | 1,600 | +235 | 3.20% | $ 1.651M |
| LIFESTANCE HEALTH GROUP INC | US53228F1012 | Equity | 124,900 | −102,200 | 3.00% | $ 1.544M |
| REVOLUTION MEDICINES INC | US76155X1000 | Equity | 7,200 | +2,696 | 2.87% | $ 1.48M |
| ILLUMINA INC | US4523271090 | Equity | 6,800 | new +6,800 | 2.82% | $ 1.453M |
| MODERNA INC | US60770K1079 | Equity | 10,000 | −8,282 | 2.72% | $ 1.403M |
| HEARTFLOW INC | US42238D1072 | Equity | 26,500 | +1,506 | 2.59% | $ 1.335M |
| SARTORIUS STEDIM BIOTECH | FR0013154002 | Equity | 5,800 | +2,167 | 2.56% | $ 1.32M |
| ALNYLAM PHARMACEUTICALS INC | US02043Q1076 | Equity | 5,000 | +1,209 | 2.33% | $ 1.203M |
| COGENT BIOSCIENCES INC | US19240Q2012 | Equity | 34,000 | +572 | 2.31% | $ 1.19M |
| INTUITIVE SURGICAL INC | US46120E6023 | Equity | 2,800 | −16 | 2.05% | $ 1.055M |
|
ASCENDIS PHARMA A/S
|
DK0060615755 | Equity | 3,865 | 0 | 1.97% | $ 1.017M |
| KYMERA THERAPEUTICS INC | US5015751044 | Equity | 8,500 | −1,500 | 1.96% | $ 1.01M |
| INSMED INC | US4576693075 | Equity | 7,775 | +900 | 1.84% | $ 947.151K |
| VAXCYTE INC | US92243G1085 | Equity | 15,571 | +1,500 | 1.83% | $ 945.783K |
|
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
|
GB00BRXB0C07 | Equity | 12,000 | 0 | 1.83% | $ 943.56K |
| EDWARDS LIFESCIENCES CORP | US28176E1082 | Equity | 10,000 | 0 | 1.76% | $ 907.5K |
| WEST PHARMACEUTICAL SVCS INC | US9553061055 | Equity | 2,600 | new +2,600 | 1.72% | $ 886.886K |
| VEEVA SYS INC | US9224751084 | Equity | 3,000 | −1,188 | 1.66% | $ 857.07K |
| UCB SA | BE0003739530 | Equity | 3,300 | −3,305 | 1.60% | $ 825.27K |
| UNITEDHEALTH GROUP INC | US91324P1021 | Equity | 2,100 | −324 | 1.59% | $ 817.761K |
| AMYLYX PHARMACEUTICALS INC | US03237H1014 | Equity | 23,554 | 0 | 1.54% | $ 794.948K |
| GUARDANT HEALTH INC | US40131M1099 | Equity | 4,975 | +600 | 1.53% | $ 791.125K |
| CARIS LIFE SCIENCES INC | US1421521071 | Equity | 30,000 | −11,991 | 1.48% | $ 764.7K |
| REPLIGEN CORP | US7599161095 | Equity | 4,200 | +1,715 | 1.47% | $ 760.116K |
| LEGEND BIOTECH CORP | US52490G1022 | Equity | 36,000 | +1,386 | 1.45% | $ 748.08K |
| BRIGHTSPRING HEALTH SERVICES INC | US10950A1060 | Equity | 12,800 | +2,613 | 1.45% | $ 747.52K |
| VIRIDIAN THERAPEUTICS INC | US92790C1045 | Equity | 31,100 | 0 | 1.40% | $ 720.276K |
| TWIST BIOSCIENCE CORP | US90184D1000 | Equity | 5,000 | new +5,000 | 1.35% | $ 695K |
| ENLIVEN THERAPEUTICS INC | US29337E1029 | Equity | 12,000 | +1,297 | 1.35% | $ 694.68K |
| BOSTON SCIENTIFIC CORP | US1011371077 | Equity | 12,185 | 0 | 1.14% | $ 588.536K |
| KESTRA MEDICAL TECHNOLOGIES INC | BMG524411052 | Equity | 22,000 | +3,600 | 1.10% | $ 566.5K |
| ROIVANT SCIENCES LTD | BMG762791017 | Equity | 16,250 | +5,000 | 1.09% | $ 562.9K |
| XENON PHARMACEUTICALS INC | CA98420N1050 | Equity | 9,266 | −5,100 | 1.08% | $ 557.999K |
| ORUKA THERAPEUTICS INC | US6876041087 | Equity | 6,000 | +5,000 | 1.08% | $ 555.72K |
| AXSOME THERAPEUTICS INC | US05464T1043 | Equity | 2,752 | 0 | 1.06% | $ 546.327K |
| DISC MEDICINE INC | US2546041011 | Equity | 6,926 | 0 | 1.06% | $ 544.73K |
| VERACYTE INC | US92337F1075 | Equity | 12,021 | −1,600 | 1.01% | $ 519.187K |
| STOKE THERAPEUTICS INC | US86150R1077 | Equity | 15,670 | 0 | 0.95% | $ 488.904K |
| WAYSTAR HOLDING CORP | US9467841055 | Equity | 18,000 | −2,187 | 0.91% | $ 471.24K |
| ELI LILLY and CO | US5324571083 | Equity | 395 | 0 | 0.89% | $ 456.908K |
| RELAY THERAPEUTICS INC | US75943R1023 | Equity | 24,000 | +11,004 | 0.86% | $ 441.12K |
| MBX BIOSCIENCES INC | US55287L1017 | Equity | 7,000 | +1,872 | 0.84% | $ 431.2K |
| DIANTHUS THERAPEUTICS INC | US2528281080 | Equity | 4,000 | new +4,000 | 0.82% | $ 422.44K |
| IRHYTHM TECHNOLOGIES INC | US4500561067 | Equity | 3,471 | 0 | 0.80% | $ 412.841K |
| ALUMIS INC | US0223071020 | Equity | 18,800 | new +18,800 | 0.80% | $ 410.028K |
| ZAI LAB LTD | US98887Q1040 | Equity | 15,273 | 0 | 0.75% | $ 388.851K |
|
NEWAMSTERDAM PHARMA COMPANY NV
|
NL00150012L7 | Equity | 15,000 | +3,878 | 0.74% | $ 380.1K |
| CYTOMX THERAPEUTICS INC | US23284F1057 | Equity | 112,069 | 0 | 0.73% | $ 376.552K |
| DEXCOM INC | US2521311074 | Equity | 4,000 | −2,533 | 0.71% | $ 364.24K |
| PRAXIS PRECISION MEDICINES INC. | US74006W2070 | Equity | 1,000 | new +1,000 | 0.68% | $ 350.3K |
| ZENAS BIOPHARMA INC | US98937L1052 | Equity | 9,817 | 0 | 0.62% | $ 317.285K |
| BRUKER CORP | US1167941087 | Equity | 5,400 | new +5,400 | 0.61% | $ 313.254K |
| ALIGNMENT HEALTHCARE INC | US01625V1044 | Equity | 22,200 | −11,178 | 0.58% | $ 297.48K |
| BRAVEHEART BIO INC | US10567X1019 | Equity | 10,000 | new +10,000 | 0.49% | $ 255K |
|
PHARVARIS BV
|
NL00150005Y4 | Equity | 7,100 | new +7,100 | 0.48% | $ 245.731K |
| SPYRE THERAPEUTICS INC | US00773J2024 | Equity | 2,600 | +2,300 | 0.45% | $ 232.258K |
| MIRUM PHARMACEUTICALS INC | US6047491013 | Equity | 2,191 | 0 | 0.42% | $ 214.828K |
| JANUX THERAPEUTICS INC | US47103J1051 | Equity | 11,754 | 0 | 0.42% | $ 214.158K |
| STRUCTURE THERAPEUTICS INC | US86366E1064 | Equity | 4,628 | 0 | 0.41% | $ 212.471K |
| CG ONCOLOGY INC | US1569441009 | Equity | 2,800 | new +2,800 | 0.41% | $ 210.448K |
| CLIMB BIO INC | US28658R1068 | Equity | 14,400 | new +14,400 | 0.38% | $ 197.712K |
| DEFINIUM THERAPEUTICS INC | CA24477V1058 | Equity | 4,800 | new +4,800 | 0.37% | $ 190.656K |
| VIKING THERAPEUTICS INC | US92686J1060 | Equity | 5,422 | 0 | 0.34% | $ 177.733K |
| UPSTREAM BIO INC | US91678A1079 | Equity | 24,900 | 0 | 0.32% | $ 164.838K |
| JADE BIOSCIENCES INC | US0080642061 | Equity | 7,426 | new +7,426 | 0.31% | $ 158.619K |
| OLEMA PHARMACEUTICALS INC | US68062P1066 | Equity | 14,950 | +3,700 | 0.30% | $ 155.929K |
|
Fidelity Revere Street Trust
|
US31635A1051 | Money market | 130,560.229 | +11,910.546 | 0.25% | $ 130.586K |
| OUTSET MEDICAL INC | US6901452069 | Equity | 34,000 | 0 | 0.25% | $ 129.88K |
| ANNEXON INC | US03589W1027 | Equity | 24,000 | new +24,000 | 0.23% | $ 118.56K |
ETFs holding FMED
Exchange-traded funds whose newest published daily portfolio holds this listing.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| FDIF | 19.82% | 681,004.2141 | $ 21.639M | Aug 31, 2026 |